======= WTAP ======= == Gene Information == * **Official Symbol**: WTAP * **Official Name**: WT1 associated protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9589|9589]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15007|Q15007]] * **Interactions**: [[https://thebiogrid.org/search.php?search=WTAP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WTAP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605442|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulatory subunit of the WMM N6-methyltransferase complex, a multiprotein complex that mediates N6-methyladenosine (m6A) methylation of some adenosine residues of some mRNAs and plays a role in the efficiency of mRNA splicing, processing and mRNA stability. Required for accumulation of METTL3 and METTL14 to nuclear speckle (PubMed:24316715, PubMed:24407421, PubMed:24981863). Acts as a mRNA splicing regulator (PubMed:12444081). Regulates G2/M cell-cycle transition by binding to the 3' UTR of CCNA2, which enhances its stability (PubMed:17088532). Impairs WT1 DNA-binding ability and inhibits expression of WT1 target genes (PubMed:17095724). {ECO:0000269|PubMed:12444081, ECO:0000269|PubMed:17088532, ECO:0000269|PubMed:17095724, ECO:0000269|PubMed:24316715, ECO:0000269|PubMed:24407421, ECO:0000269|PubMed:24981863}. No Pfam Domain information is available for this gene. |RNA N6-methyladenosine methyltransferase complex| |mRNA methylation| |mRNA modification| |regulation of alternative mRNA splicing, via spliceosome| |RNA methylation| |regulation of mRNA splicing, via spliceosome| |regulation of RNA splicing| |regulation of mRNA processing| |RNA modification| |nuclear membrane| |macromolecule methylation| |methylation| |regulation of mRNA metabolic process| |RNA splicing| |nuclear speck| |mRNA processing| |mRNA metabolic process| |RNA processing| |cell cycle| |RNA metabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-2.13| |[[:results:exp359|FK-506 30μM R07 exp359]]|-2.05| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|-2.01| |[[:results:exp326|CCT251545 20μM R07 exp326]]|-1.89| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|-1.88| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|-1.88| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.87| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.74| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-1.71| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-1.7| |[[:results:exp274|Citral 50μM R06 exp274]]|1.71| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|1.75| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.76| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|1.78| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|1.83| |[[:results:exp185|L-BMAA 500 to 750μM on day4 R04 exp185]]|1.86| |[[:results:exp432|YM155 0.001μM R08 exp432]]|1.95| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|2| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.04| |[[:results:exp246|UM0011500 10μM R05 exp246]]|2.24| |[[:results:exp11|CCCP 1μM R00 exp11]]|2.32| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.68| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 67/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|4/28| |blood|2/28| |bone|0/26| |breast|5/33| |central nervous system|1/56| |cervix|1/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|4/16| |kidney|0/21| |liver|0/20| |lung|6/75| |lymphocyte|1/16| |ovary|4/26| |pancreas|2/24| |peripheral nervous system|1/16| |plasma cell|4/15| |prostate|0/1| |skin|2/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|5/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2264 * **Expression level (log2 read counts)**: 7.33 {{:chemogenomics:nalm6 dist.png?nolink |}}